Prokar Dasgupta has had 30 years’ experience at the earlier stages of his career working with large, multi-disciplinary research teams. His initial focus was on the immunology of Leishmaniasis and the role of effect of splenectomy on drug refractory disease. While at Queens Square, London he studied C-nerve fibres in the human bladder and developed the “Dasgupta technique” of injecting Botulinum Toxin (Botox) into these nerves to treat overactivity with a flexible telescope, which has helped nearly 5 million patients world-wide. Prokar is regarded as a pioneering robotic surgeon and has concentrated on improving the surgical research environment, developing large research-intensive institutes and successful industry-academic partnerships.
Prokar Dasgupta is chief investigator of three key randomised trials, CORAL (Cystectomy Open, Robotic and Laparoscopic), STAR-TRAK (Systematic Trans-Atlantic Randomised Tele-Robotic Access to the Kidney) and SIMULATE (Simulation in Learning and Teaching) in surgical sciences. He directs the Prostate Cancer Research Centre at KCL with a major translational interest in the immunology of prostate cancer. He is the Ambassador for the KCL-Ericsson 5G Global Health Program in telemedicine and was awarded the Golden Telescope in 2006 for significant and lasting contribution to his specialty. In 2020 Prokar was awarded the St. Peter’s Medal, the highest award from the British Association of Urological Surgeons (BAUS).